 | |
| Company type | Public |
|---|---|
| Nasdaq: TLRY TSX: TLRY | |
| Industry | Cannabis, Pharmaceutical |
| Founded | 2013 |
| Founder | Brendan Kennedy |
| Headquarters | New York City , United States |
Key people | Irwin D. Simon (CEO) |
| Revenue |  US$627 million (2023) |
| US$-1.44 billion (2023) | |
Number of employees | 1,600 (2023) |
| Website | tilray |
Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City.[1][2] Tilray also has operations in Canada, Australia, New Zealand,[3][4] and Latin America,[5] with growing facilities in Germany and Portugal.[6][7]
In December 2020, the company announced a merger with Aphria, and will operate under the Tilray name and its ticker symbol on NASDAQ[8] and the Toronto Stock Exchange.[9]
Tilray also owns several breweries and is the 5th largest craft beer company in the US.
- ^ "Tilray Focuses on Brand Growth in Crowded Canada Pot Market". Bloomberg. January 10, 2022. Retrieved March 1, 2022.
- ^ "Tilray Brands, Inc. Class 2 Common Stock (TLRY)".
- ^ SmallCapPower (August 8, 2018). "Tilray Stands Out with its Global Supply Agreements".
- ^ "Tilray exports medical cannabis to New Zealand for national dispersal". Marijuana Business Daily. October 2, 2017.
- ^ "Tilray sets up Latin American subsidiary". Seeking Alpha. December 3, 2018.
- ^ Commodities; Agriculture (September 7, 2017). "Tilray to build $30 million EU cannabis production operation in Portugal - Financial Post".
- ^ Owusu, Tony (January 12, 2022). "Tilray Stock: As Germany Closes in on Legal Cannabis, Rest of Europe Might Follow". TheStreet. Retrieved March 1, 2022.
- ^ Kary, Tiffany (December 15, 2020). "Aphria, Tilray combine to create biggest cannabis company". Bloomberg. Retrieved January 15, 2021.
- ^ "Tilray Commences Trading on the Toronto Stock Exchange Under Symbol "TLRY"" (Press release). National Post. Business Wire. May 5, 2021.